-The Hindu   Top civil society bodies are challenging the government's ‘counter-affidavit' in the Paid News case which seeks to gut the Election Commission's powers In a major twist to the Ashok Chavan vs. Madhav Kinhalkar legal battle (more notorious as the "Paid News" scandal), leading civil society organisations and eminent individuals have approached the Supreme Court to implead themselves into the case. Their intervention application, moved by advocate Prashant Bhushan, minces no words...

-The Indian Express Until recently, we took a compartmentalised view of national security. Each threat to national security was neatly fitted into one compartment. The first, of course, was a war with Pakistan. That was fitted into a compartment and was meant to be deterred, or defended, through the might of our armed forces. A war with China was, and remains, unthinkable, and therefore that threat was fitted into another compartment...

-The Times of India LONDON: The 2009 global H5N1 swine flu Pandemic - the first in over 41 years that swept throughout the globe in record time -- infected at least one in five Indians with the highest rates of infection being among children. A joint Imperial College, London, and the World Health Organization global study released on Saturday found that 47% of those aged five to 19 showed signs of having...

-The United Nations The United Nations agency tasked with advancing gender equality today announced a new initiative that will spotlight countries’ commitments to end violence against women and girls, seeking bold action and leadership to galvanize efforts to end the Pandemic. “We all must do better to protect women and prevent this pervasive human rights violation,” said the Executive Director of the UN Entity for Gender Equity and the Empowerment of Women...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...